ALDX - Aldeyra Therapeutics, Inc.
1.57
-0.010 -0.637%
Share volume: 724,956
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$1.58
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-28-2025 | 05-14-2025 | 08-07-2025 | 11-05-2025 | 02-27-2026 | |
| Assets | |||||||||
| Total Assets | 141.302 M | 126.044 M | 117.319 M | 104.607 M | 93.196 M | 84.963 M | 77.801 M | 72.059 M | |
| Current Assets | 140.846 M | 125.650 M | 116.721 M | 104.072 M | 92.729 M | 84.558 M | 77.460 M | 71.783 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 30.545 M | 49.302 M | 44.624 M | 46.624 M | 39.707 M | 40.678 M | 15.957 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 102.492 M | 71.030 M | 68.120 M | 54.527 M | 50.351 M | 41.241 M | 59.341 M | 70.041 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.079 K | 2.720 K | 1.360 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 451.867 K | 391.595 K | 597.229 K | 534.216 K | 466.942 K | 404.660 K | 340.977 K | 275.861 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 141.302 M | 126.044 M | 117.319 M | 104.607 M | 93.196 M | 84.963 M | 77.801 M | 72.059 M | |
| Total liabilities | 27.882 M | 27.733 M | 32.224 M | 33.602 M | 29.597 M | 29.675 M | 28.556 M | 27.809 M | |
| Total current liabilities | 21.676 M | 27.595 M | 17.153 M | 18.602 M | 14.286 M | 29.531 M | 28.484 M | 27.809 M | |
| Accounts Payable | 280.299 K | 254.434 K | 186.919 K | 180.453 K | 346.146 K | 1.455 M | 13.423 K | 158.461 K | |
| Other liabilities | 6.206 M | 138.893 K | 70.234 K | 0.000 | 212.769 K | 143.447 K | 72.536 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 15.000 M | 15.000 M | 15.099 M | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 6.206 M | 138.893 K | 70.234 K | 0.000 | 212.769 K | 143.447 K | 72.536 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 113.419 M | 98.310 M | 85.096 M | 71.005 M | 63.599 M | 55.288 M | 49.245 M | 44.250 M | |
| Common stock | 515.764 M | 517.509 M | 519.331 M | 521.078 M | 523.637 M | 525.107 M | 526.739 M | 528.208 M | |
| Retained earnings | -402.341 M | -419.189 M | -434.302 M | -450.111 M | -460.040 M | -469.807 M | -477.496 M | -483.957 M |